Cargando…

Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study

OBJECTIVE: Patients with Lennox‐Gastaut syndrome (LGS) who completed 1 of 2 randomized, double‐blind, placebo‐controlled trials of add‐on cannabidiol (CBD) (GWPCARE3, NCT02224560 or GWPCARE4, NCT02224690) were invited to enroll in an open‐label extension (OLE) study evaluating the long‐term safety a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiele, Elizabeth, Marsh, Eric, Mazurkiewicz‐Beldzinska, Maria, Halford, Jonathan J., Gunning, Boudewijn, Devinsky, Orrin, Checketts, Daniel, Roberts, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850399/ https://www.ncbi.nlm.nih.gov/pubmed/30740695 http://dx.doi.org/10.1111/epi.14670

Ejemplares similares

Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials
por: Privitera, Michael, et al.
Publicado: (2021)

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
por: Devinsky, Orrin, et al.
Publicado: (2018)

Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020)

Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
por: Koo, Chung Mo, et al.
Publicado: (2020)

Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials
por: Gunning, Boudewijn, et al.
Publicado: (2020)

Lennox-Gastaut syndrome: An overview
por: Ramanathan, Ramnath Santhosh, et al.
Publicado: (2010)

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study
por: Knupp, Kelly G., et al.
Publicado: (2022)

Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials
por: Madan Cohen, Jennifer, et al.
Publicado: (2021)

Lennox-Gastaut syndrome: Management update
por: Al-Banji, Muradi H., et al.
Publicado: (2015)

Lennox-Gastaut Syndrome: In a Nutshell
por: Jahngir, Muhammad Umair, et al.
Publicado: (2018)

Lennox-Gastaut Syndrome in Mitochondrial Disease
por: Lee, Soonie, et al.
Publicado: (2019)

Ophthalmologic Features of Lennox-Gastaut Syndrome
por: Kim, Bo Hee, et al.
Publicado: (2017)

Lennox-Gastaut and Schizophrenia: Comorbidity or complication?
por: Bencharfa, Z., et al.
Publicado: (2022)

Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years
por: Conry, Joan A, et al.
Publicado: (2014)

Novel seizure outcomes in patients with Lennox‐Gastaut syndrome: Post hoc analysis of seizure‐free days in rufinamide Study 303
por: Auvin, Stéphane, et al.
Publicado: (2019)

Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
por: Silvinato, Antônio, et al.
Publicado: (2022)

The Curious Case of Lennox-Gastaut Syndrome: Treatment-Resistant Seizures in a Patient With Autism Spectrum Disease With Lennox-Gastaut Syndrome
por: Anvekar, Priyanka, et al.
Publicado: (2021)

Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
por: Hollenack, Kelly, et al.
Publicado: (2021)

Caregivers’ Perspectives on the Impact of Cannabidiol (CBD) Treatment for Dravet and Lennox-Gastaut Syndromes: A Multinational Qualitative Study
por: Marshall, Jade, et al.
Publicado: (2023)

Treatment of Lennox-Gastaut syndrome: overview and recent findings
por: van Rijckevorsel, Kenou
Publicado: (2008)

Surgical Treatment of Patients with Lennox-Gastaut Syndrome Phenotype
por: Liu, Shi-Yong, et al.
Publicado: (2012)

Anaesthetic management in a patient with Lennox-Gastaut syndrome
por: Dhansura, Tasneem, et al.
Publicado: (2014)

Lennox–Gastaut syndrome: impact on the caregivers and families of patients
por: Gibson, Patricia A
Publicado: (2014)

Quantifying the burden of disease in patients with Lennox Gastaut syndrome
por: Spoor, Jochem K.H., et al.
Publicado: (2021)

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome
por: Iannone, Luigi Francesco, et al.
Publicado: (2021)

Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials
por: Devinsky, Orrin, et al.
Publicado: (2020)

Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results
por: Szaflarski, Jerzy P., et al.
Publicado: (2018)

Lennox gastaut syndrome, review of the literature and a case report
por: Abu Saleh, Tareq, et al.
Publicado: (2008)

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Stafstrom, Carl E
Publicado: (2009)

Conceptualizing Lennox–Gastaut Syndrome as a Secondary Network Epilepsy
por: Archer, John S., et al.
Publicado: (2014)

Lennox–Gastaut Syndrome: A Prospective Follow-up Study
por: Rathaur, Bhanu Pratap, et al.
Publicado: (2017)

Centromedian thalamic responsive neurostimulation for Lennox‐Gastaut epilepsy and autism
por: Kwon, Churl‐Su, et al.
Publicado: (2020)

Effect of Cannabinoids on Electroencephalography of a Child with Lennox–Gastaut Syndrome
por: Prakash, Vikram
Publicado: (2020)

Unilateral Lennox–Gastaut syndrome associated with Klippel–Trénaunay syndrome
por: Tabarki, Brahim, et al.
Publicado: (2021)

Lennox–Gastaut Syndrome: Perspective of a Parent and a Physician
por: McKee, Heather R., et al.
Publicado: (2020)

ADHD in the context of Lennox Gastaut Syndrome: A rare presentation
por: B, Kavitha, et al.
Publicado: (2022)

Ketogenic Diets in the Management of Lennox-Gastaut Syndrome—Review of Literature
por: Skrobas, Urszula, et al.
Publicado: (2022)

Budget Impact Analysis of Antiepileptic Drugs for Lennox-Gastaut Syndrome
por: Skornicki, Michelle, et al.
Publicado: (2014)

Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4bb4d40gtgl21pd8iko77tpin5